Low intensity therapies clinical trials

IMPACT-AML: A Randomized Pragmatic Clinical Trial for Relapsed or Refractory Acute Myeloid Leukemia.

This study looks at new ways to treat acute myeloid leukaemia (AML) that has come back or hasn't responded to earlier treatment. It compares stronger treatments with gentler ones to see which works best for patients in their first or second relapse.